Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,634 | -70,550 | -45,555 | -27,052 | -90,751 |
| Depreciation Amortization | -1,241 | -1,126 | -881 | -457 | 414 |
| Income taxes - deferred | -774 | -33 | -18 | -7 | 1,099 |
| Accounts receivable | -944 | -514 | -473 | -557 | -156 |
| Other Working Capital | -9,527 | -9,343 | -9,440 | -4,192 | -4,205 |
| Other Operating Activity | 26,053 | 18,027 | 11,423 | 8,326 | 28,641 |
| Operating Cash Flow | $-84,067 | $-63,539 | $-44,944 | $-23,939 | $-64,958 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,554 | -1,539 | -1,539 | -1,488 | -340 |
| Purchase Of Investment | -281,334 | -149,327 | -93,667 | -49,030 | -183,941 |
| Sale Of Investment | 232,570 | 195,570 | 132,091 | 61,953 | 48,884 |
| Investing Cash Flow | $-50,318 | $44,704 | $36,885 | $11,435 | $-135,397 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 135,408 | 2,231 | 846 | 140 | 155,833 |
| Other Financing Activity | 4,238 | 0 | 0 | 0 | 3,960 |
| Financing Cash Flow | $139,646 | $2,231 | $846 | $140 | $159,793 |
| Beginning Cash Position | 41,471 | 41,471 | 41,471 | 41,471 | 82,033 |
| End Cash Position | 46,732 | 24,867 | 34,258 | 29,107 | 41,471 |
| Net Cash Flow | $5,261 | $-16,604 | $-7,213 | $-12,364 | $-40,562 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,067 | -63,539 | -44,944 | -23,939 | -64,958 |
| Capital Expenditure | -1,554 | -1,539 | -1,539 | -1,488 | -340 |
| Free Cash Flow | -85,621 | -65,078 | -46,483 | -25,427 | -65,298 |